Fosamax Femur Fracture
May 16th, 2011
Long-term use of the drug Fosamax, a Bisphosphonate, may increase the risk of low-energy bone fractures, involving the thigh bone or femur. A study published in The Journal of American Medical Association on February 23, 2011, concludes that prolonged Bisphosphonate use leads to devastating femur fractures. Normally a large amount of force is required to break this bone. Ironically, Fosamax is designed to prevent bone loss and reduce the risk of broken bones.
Fosamax is prescribed to treat osteoporosis and reduce the risk of hip fractures and long bone fractures. However, side effects of Fosamax may weaken the ability of the bone to repair itself from microdamage, increasing the risk of a bone fracture over time.
If you, a family member or loved one suffered a femur fracture or other side effects as a result of using Fosamax, contact the attorneys at Pendley, Baudin and Coffin, L.L.P. to have your potential case confidentially evaluated.
This entry was posted in Current Cases, firm-news. Bookmark the permalink.Comments are closed.